PL338017A1 - Novel composition - Google Patents

Novel composition

Info

Publication number
PL338017A1
PL338017A1 PL98338017A PL33801798A PL338017A1 PL 338017 A1 PL338017 A1 PL 338017A1 PL 98338017 A PL98338017 A PL 98338017A PL 33801798 A PL33801798 A PL 33801798A PL 338017 A1 PL338017 A1 PL 338017A1
Authority
PL
Poland
Prior art keywords
novel composition
novel
composition
Prior art date
Application number
PL98338017A
Other languages
English (en)
Inventor
Paul John Cummings
Ian Frederic Tulloch
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of PL338017A1 publication Critical patent/PL338017A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Addiction (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Child & Adolescent Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
PL98338017A 1997-07-11 1998-07-07 Novel composition PL338017A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9714675.7A GB9714675D0 (en) 1997-07-11 1997-07-11 Novel composition
PCT/EP1998/004971 WO1999002142A2 (fr) 1997-07-11 1998-07-07 Nouvelle composition

Publications (1)

Publication Number Publication Date
PL338017A1 true PL338017A1 (en) 2000-09-25

Family

ID=10815744

Family Applications (1)

Application Number Title Priority Date Filing Date
PL98338017A PL338017A1 (en) 1997-07-11 1998-07-07 Novel composition

Country Status (26)

Country Link
EP (1) EP0996466A2 (fr)
JP (1) JP2002508003A (fr)
KR (1) KR20010021644A (fr)
CN (1) CN1262627A (fr)
AP (1) AP2000001728A0 (fr)
AR (1) AR016128A1 (fr)
AU (1) AU9340198A (fr)
BG (1) BG104119A (fr)
BR (1) BR9810996A (fr)
CA (1) CA2295822A1 (fr)
CO (1) CO4950552A1 (fr)
DZ (1) DZ2556A1 (fr)
EA (1) EA200000112A1 (fr)
GB (1) GB9714675D0 (fr)
HU (1) HUP0003074A3 (fr)
ID (1) ID24191A (fr)
IL (1) IL133869A0 (fr)
MA (1) MA24604A1 (fr)
NO (1) NO20000107L (fr)
OA (1) OA11276A (fr)
PE (1) PE99699A1 (fr)
PL (1) PL338017A1 (fr)
SK (1) SK72000A3 (fr)
TR (1) TR200000074T2 (fr)
WO (1) WO1999002142A2 (fr)
ZA (1) ZA986138B (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69942009D1 (de) 1998-10-15 2010-03-25 Imp Innovations Ltd Verbindungen für die behandlung von gewichtsverlust
IL142896A0 (en) 1998-11-02 2002-04-21 Elan Corp Plc Multiparticulate modified release composition
US10179130B2 (en) 1999-10-29 2019-01-15 Purdue Pharma L.P. Controlled release hydrocodone formulations
EP2295043A1 (fr) 1999-10-29 2011-03-16 Euro-Celtique S.A. Formulations d'hydrocodone à liberation lente
GB0004003D0 (en) * 2000-02-22 2000-04-12 Knoll Ag Therapeutic agents
AU2002227383B2 (en) 2000-10-30 2004-07-08 Euro-Celtique S.A. Controlled release hydrocodone formulations
WO2006030306A2 (fr) * 2004-09-17 2006-03-23 Neurocure Ltd Methodes et compositions pour le traitement du syndrome premenstruel (pms) et d'un trouble dysphorique premenstruel (pmdd)
CN100469356C (zh) * 2006-09-08 2009-03-18 山东益康药业有限公司 复方阿替洛尔缓释片及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2732335C2 (de) * 1976-07-27 1983-01-20 Sandoz-Patent-GmbH, 7850 Lörrach Tablette zur enteralen Verabreichung von Indolyloxyalkanolamin-Derivaten
CA2134038C (fr) * 1994-06-16 1997-06-03 David Taiwai Wong Potentialisation des effets de medicaments
EP0714663A3 (fr) * 1994-11-28 1997-01-15 Lilly Co Eli Potentialisation d'un médicament par un antagoniste du récepteur sérotonine 1A
PT759299E (pt) * 1995-08-16 2000-09-29 Lilly Co Eli Potenciacao da resposta de serotonina
EP0792649A1 (fr) * 1996-02-29 1997-09-03 Eli Lilly And Company Traitement de l'insomnie

Also Published As

Publication number Publication date
OA11276A (en) 2003-07-31
HUP0003074A3 (en) 2001-12-28
EA200000112A1 (ru) 2000-10-30
BR9810996A (pt) 2000-08-08
AU9340198A (en) 1999-02-08
HUP0003074A2 (hu) 2001-01-29
CA2295822A1 (fr) 1999-01-21
ID24191A (id) 2000-07-13
TR200000074T2 (tr) 2000-05-22
CO4950552A1 (es) 2000-09-01
WO1999002142A2 (fr) 1999-01-21
WO1999002142A3 (fr) 1999-04-15
ZA986138B (en) 2000-01-10
CN1262627A (zh) 2000-08-09
JP2002508003A (ja) 2002-03-12
BG104119A (en) 2000-12-29
EP0996466A2 (fr) 2000-05-03
NO20000107D0 (no) 2000-01-10
SK72000A3 (en) 2000-12-11
NO20000107L (no) 2000-01-10
MA24604A1 (fr) 1999-04-01
KR20010021644A (ko) 2001-03-15
GB9714675D0 (en) 1997-09-17
DZ2556A1 (fr) 2003-02-15
AP2000001728A0 (en) 2000-03-31
PE99699A1 (es) 1999-12-21
IL133869A0 (en) 2001-04-30
AR016128A1 (es) 2001-06-20

Similar Documents

Publication Publication Date Title
GB9726814D0 (en) Compositions
GB9704524D0 (en) Composition
GB9702238D0 (en) Compositions
GB9715203D0 (en) Composition
GB9713620D0 (en) Composition
GB9711683D0 (en) Composition
GB9726543D0 (en) Novel compositions
GB9715489D0 (en) Composition
GB9714010D0 (en) Composition
GB9726777D0 (en) Composition
GB9714675D0 (en) Novel composition
GB9726284D0 (en) Composition
GB9714359D0 (en) Composition
GB9701031D0 (en) Composition
GB9826467D0 (en) Composition
GB9724975D0 (en) Composition
GB9705813D0 (en) Novel compositions
GB9705110D0 (en) Composition
EG23068A (en) Pesticidale composition
ZA986934B (en) Composition
GB9722706D0 (en) Composition
GB9722707D0 (en) Composition
GB9718910D0 (en) Composition
GB9716806D0 (en) Composition
GB9719932D0 (en) Composition